Priscilla Moonsamy

Title: Priscilla Moonsamy: Innovator in Transplant Rejection Detection

Introduction

Priscilla Moonsamy is a notable inventor based in Pleasanton, CA (US). She has made significant contributions to the field of medical diagnostics, particularly in the area of organ transplantation. Her innovative work focuses on the early detection of solid organ transplant rejection, which is crucial for improving patient outcomes.

Latest Patents

Priscilla holds a patent for a groundbreaking invention titled "Non-invasive early detection of solid organ transplant rejection by quantitative analysis of mixtures by deep sequencing of HLA gene amplicons using next generation systems." This method allows for the detection and assessment of solid organ graft rejection by identifying donor-specific HLA alleles in a blood sample from a transplant recipient. Additionally, her invention includes a method for detecting the presence of maternal cells in the blood sample of an offspring. She has 1 patent to her name.

Career Highlights

Throughout her career, Priscilla has worked with esteemed organizations such as Roche Molecular Systems, Inc. and The Scripps Research Institute. Her experience in these institutions has allowed her to develop and refine her innovative techniques in the field of transplant medicine.

Collaborations

Priscilla has collaborated with notable professionals in her field, including Henry A. Erlich and Bryan Hoglund. These partnerships have contributed to the advancement of her research and the successful development of her patented methods.

Conclusion

Priscilla Moonsamy is a pioneering inventor whose work in the detection of transplant rejection has the potential to transform patient care in organ transplantation. Her innovative methods and collaborations highlight her commitment to advancing medical science.